Activist Strategies for Increasing Access to HCV Treatment in Low- and Middle-Income Countries

Activist Strategies for HCV Tx 1

Activist Strategies for HCV Tx_0

Drugs that can cure hepatitis C virus (HCV) are on the market in some countries. But these drugs are unaffordable for most of the 150 million people living with hepatitis C globally –90% of whom live in resource-limited settings. Activism to overcome pricing and other barriers to treatment is urgently needed.

TAG is pleased to release Activist Strategies for Increasing Access to HCV Treatment in Low- and Middle-Income Countries. This guide presents key strategies through real-world case studies, and shows how strategies used to combat the AIDS epidemic can be—and have been—adapted to increase HCV treatment access.

We hope you find this document useful in your global treatment advocacy work. Please share widely with relevant stakeholders.

These strategies are introduced in three sections:

Section One: Laying the Groundwork through Community Organizing

Strategy 1: Framing HCV Treatment and Prevention as Basic Human Rights, Particularly for Injection Drug Users
Strategy 2: Organizing People Living with HCV for Community Education and Mobilization
Strategy 3: Forming Alliances with Local, Regional, and Global Organizations to Influence Policy
Strategy 4: Demanding Global HCV Policies and Funding Streams

Section Two: Overcoming the Cost Barriers to HCV Treatment Access

Strategy 5: Negotiating Lower Prices with Drug Companies
Strategy 6: Challenging Intellectual Property Barriers through Patent Oppositions
Strategy 7: Overriding Patent Barriers through Compulsory Licenses and Parallel Importation

Section Three: Collaborating with Researchers to Build Your Case for HCV Treatment Access

Strategy 8: Using Mathematical Modeling to Predict Cost-Effectiveness and Public Health Benefits of HCV Treatment
Strategy 9: Advocating for Policies and Programs Based on Evidence Provided by Operational Research